Similar articles for PMID: 20625110

Year	Number of Results
1989	1
1994	1
1995	1
1996	2
1997	3
1998	1
2000	1
2001	2
2003	1
2004	1
2005	7
2006	6
2007	5
2008	14
2009	17
2010	17
2011	11
2012	17
2013	32
2014	15
2015	6
2016	12
2017	4
2018	4
2019	5
2020	8
2021	5
2022	9
2023	3
2024	0

1

Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.

Varma N, Epstein AE, Irimpen A, Schweikert R, Love C; TRUST Investigators. Varma N, et al. Circulation. 2010 Jul 27;122(4):325-32. doi: 10.1161/CIRCULATIONAHA.110.937409. Epub 2010 Jul 12. Circulation. 2010. PMID: 20625110 Clinical Trial.

2

Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.

Varma N, Michalski J, Epstein AE, Schweikert R. Varma N, et al. Circ Arrhythm Electrophysiol. 2010 Oct;3(5):428-36. doi: 10.1161/CIRCEP.110.951962. Epub 2010 Aug 17. Circ Arrhythm Electrophysiol. 2010. PMID: 20716717 Clinical Trial.

3

Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.

Varma N. Varma N. Am Heart J. 2007 Dec;154(6):1029-34. doi: 10.1016/j.ahj.2007.07.051. Epub 2007 Sep 27. Am Heart J. 2007. PMID: 18035071 Clinical Trial.

4

Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.

Heidbüchel H, Lioen P, Foulon S, Huybrechts W, Ector J, Willems R, Ector H. Heidbüchel H, et al. Europace. 2008 Mar;10(3):351-7. doi: 10.1093/europace/eun010. Epub 2008 Feb 1. Europace. 2008. PMID: 18245771

5

Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.

Spencker S, Coban N, Koch L, Schirdewan A, Müller D. Spencker S, et al. Europace. 2009 Apr;11(4):483-8. doi: 10.1093/europace/eun350. Epub 2008 Dec 22. Europace. 2009. PMID: 19103654

6

Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.

Lazarus A. Lazarus A. Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S2-S12. doi: 10.1111/j.1540-8159.2007.00595.x. Pacing Clin Electrophysiol. 2007. PMID: 17302706

7

Role of Automatic Wireless Remote Monitoring Immediately Following ICD Implant: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Trial.

Varma N, Epstein AE, Schweikert R, Michalski J, Love CJ; TRUST Investigators. Varma N, et al. J Cardiovasc Electrophysiol. 2016 Mar;27(3):321-6. doi: 10.1111/jce.12895. Epub 2016 Jan 27. J Cardiovasc Electrophysiol. 2016. PMID: 26661687 Clinical Trial.

8

Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.

Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M. Landolina M, et al. Circulation. 2012 Jun 19;125(24):2985-92. doi: 10.1161/CIRCULATIONAHA.111.088971. Epub 2012 May 24. Circulation. 2012. PMID: 22626743 Clinical Trial.

9

Automatic home monitoring of implantable cardioverter defibrillators.

Nielsen JC, Kottkamp H, Zabel M, Aliot E, Kreutzer U, Bauer A, Schuchert A, Neuser H, Schumacher B, Schmidinger H, Stix G, Clémenty J, Danilovic D, Hindricks G. Nielsen JC, et al. Europace. 2008 Jun;10(6):729-35. doi: 10.1093/europace/eun099. Epub 2008 Apr 22. Europace. 2008. PMID: 18434298 Clinical Trial.

10

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Day JD, et al. Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30. Circulation. 2007. PMID: 17470697 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

188 results

Results by year